|
⚲
|
| Keyboard |
| Stephen From | |
|---|---|
| Firm | Goldman Sachs Asset Management LP |
| Address | 78 Fourth Avenue Waltham, MA 02451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Goldman Sachs Asset Management LP | |||||
| Des MSF Holdings LLC | 021-560942 | Executive Officer | 11.7 M of 11.7 M |
17.3 M | |
| Eyegate Pharmaceuticals Inc | 021-419911 | Executive Officer | 0.1 M | ||
| Eyegate Pharmaceuticals Inc | 021-410958 | Executive Officer | 10.8 M of 10.8 M |
||
| Eyegate Pharmaceuticals Inc | 021-386998 | Executive Officer | 8.0 M of 8.0 M |
||
| Eyegate Pharmaceuticals Inc | 021-385028 | Executive Officer | 3.2 M | ||
| Eyegate Pharmaceuticals Inc | 021-358165 | Executive Officer | |||
| Eyegate Pharmaceuticals Inc | 021-350635 | Executive Officer | 1.9 M of 1.9 M |
||
| Eyegate Pharmaceuticals Inc | 021-266554 | Executive Officer | 3.8 M of 3.8 M |
||
| Eyegate Pharmaceuticals Inc | 021-259702 | Executive Officer | 2.6 M of 2.6 M |
||
| Eyegate Pharmaceuticals Inc | 021-221723 | Executive Officer | 1.0 M of 2.0 M |
||
| Eyegate Pharmaceuticals Inc | 021-203605 | Executive Officer | 1.0 M of 1.4 M |
||
| Eyegate Pharmaceuticals Inc | 021-153029 | Executive Officer | 4.5 M of 4.5 M |
||
| Eyegate Pharmaceuticals Inc | 021-93705 | Executive Officer | 11.1 M of 22.6 M |
||